Travelers' diarrhea

Last updated
Travelers' diarrhea
Other namesTravellers' diarrhoea, tourist diarrhea, [1] traveler's dysentery [1]
E coli at 10000x, original.jpg
The bacterium E. coli, the most common cause of Travelers' diarrhea
Specialty Infectious diseases   OOjs UI icon edit-ltr-progressive.svg
Symptoms Unformed stool while traveling, fever, abdominal cramps, headache [2] [3]
DurationTypically < 5 days [3]
CausesOften bacterial [3]
Risk factors Travel in the developing world
Diagnostic method Based on symptoms and travel history
PreventionEating only properly prepared food, drinking bottled water, frequent hand washing [4]
Treatment Oral rehydration therapy, antibiotics, loperamide [3] [4]
Frequency~35% of travelers to the developing world [3]

Travelers' diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. [2] [3] It may be accompanied by abdominal cramps, nausea, fever, headache and bloating. [3] Occasionally bloody diarrhea may occur. [5] Most travelers recover within three to four days with little or no treatment. [3] About 12% of people may have symptoms for a week. [3]

Contents

Bacteria are responsible for more than half of cases, [3] typically via foodborne illness and waterborne diseases. The bacteria enterotoxigenic Escherichia coli (ETEC) are typically the most common except in Southeast Asia, where Campylobacter is more prominent. [2] [3] About 10 to 20 percent of cases are due to norovirus. [3] Protozoa such as Giardia may cause longer term disease. [3] The risk is greatest in the first two weeks of travel and among young adults. [2] People affected are more often from the developed world. [2]

Recommendations for prevention include eating only properly cleaned and cooked food, drinking bottled water, and frequent hand washing. [4] The oral cholera vaccine, while effective for cholera, is of questionable use for travelers' diarrhea. [6] Preventive antibiotics are generally discouraged. [3] Primary treatment includes rehydration and replacing lost salts (oral rehydration therapy). [3] [4] Antibiotics are recommended for significant or persistent symptoms, and can be taken with loperamide to decrease diarrhea. [3] Hospitalization is required in less than 3 percent of cases. [2]

Estimates of the percentage of people affected range from 20 to 50 percent among travelers to the developing world. [3] TD is particularly common among people traveling to Asia (except for Japan and Singapore), the Middle East, Africa, Latin America, and Central and South America. [4] [7] The risk is moderate in Southern Europe, Russia, and China. [8] TD has been linked to later irritable bowel syndrome and Guillain–Barré syndrome. [2] [3] It has colloquially been known by a number of names, including "Montezuma's revenge," the "Nile runs", "Delhi belly" [9] and the "Thailand trots".

Signs and symptoms

The onset of TD usually occurs within the first week of travel, but may occur at any time while traveling, and even after returning home, depending on the incubation period of the infectious agent. [10] Bacterial TD typically begins abruptly, but Cryptosporidium may incubate for seven days, and Giardia for 14 days or more, before symptoms develop. Typically, a traveler experiences four to five loose or watery bowel movements each day. Other commonly associated symptoms are abdominal cramping, bloating, fever, and malaise. Appetite may decrease significantly. [11] Though unpleasant, most cases of TD are mild, and resolve in a few days without medical intervention. [12]

Blood or mucus in the diarrhea, significant abdominal pain, or high fever suggests a more serious cause, such as cholera, characterized by a rapid onset of weakness and torrents of watery diarrhea with flecks of mucus (described as "rice water" stools). Medical care should be sought in such cases; dehydration is a serious consequence of cholera, and may trigger serious sequelae—including, in rare instances, death—as rapidly as 24 hours after onset if not addressed promptly. [12]

Causes

E. coli , enterotoxigenic20–75%
E. coli, enteroaggregative0–20%
E. coli, enteroinvasive0–6%
Shigella spp.2–30%
Salmonella spp.0–33%
Campylobacter jejuni 3–17%
Vibrio parahaemolyticus 0–31%
Aeromonas hydrophila 0–30%
Giardia lamblia 0–20%
Entamoeba histolytica 0–5%
Cryptosporidium spp.0–20%
Cyclospora cayetanensis  ?
Rotavirus 0–36%
Norovirus 0–10%

Infectious agents are the primary cause of travelers' diarrhea. Bacterial enteropathogens cause about 80% of cases. Viruses and protozoans account for most of the rest. [11]

The most common causative agent isolated in countries surveyed has been enterotoxigenic Escherichia coli (ETEC). [11] Enteroaggregative E. coli is increasingly recognized. [12] Shigella spp. and Salmonella spp. are other common bacterial pathogens. Campylobacter , Yersinia , Aeromonas , and Plesiomonas spp. are less frequently found. Mechanisms of action vary: some bacteria release toxins which bind to the intestinal wall and cause diarrhea; others damage the intestines themselves by their direct presence.[ citation needed ]

Brachyspira pilosicoli pathogen also appears to be responsible for many chronic intermittent watery diarrhea and is only diagnosed through colonic biopsies and microscopic discovery of a false brush border [13] on H&E or Warthin silver stain: its brush-border is stronger and longer that Brachyspira aalborgi's brush-border. It is unfortunately often not diagnosed as coproculture does not allow growth and 16S PCR panel primers do not match Brachyspira sequences. [14]

While viruses are associated with less than 20% of adult cases of travelers' diarrhea, they may be responsible for nearly 70% of cases in infants and children. Diarrhea due to viral agents is unaffected by antibiotic therapy, but is usually self-limited. [12] Protozoans such as Giardia lamblia , Cryptosporidium and Cyclospora cayetanensis can also cause diarrhea. Pathogens commonly implicated in travelers' diarrhea appear in the table in this section. [12] [15]

A subtype of travelers' diarrhea afflicting hikers and campers, sometimes known as wilderness diarrhea, may have a somewhat different frequency of distribution of pathogens. [16]

Risk factors

The primary source of infection is ingestion of fecally contaminated food or water. Attack rates are similar for men and women. [11]

The most important determinant of risk is the traveler's destination. High-risk destinations include developing countries in Latin America, Africa, the Middle East, and Asia. [11] Among backpackers, additional risk factors include drinking untreated surface water and failure to maintain personal hygiene practices and clean cookware. [17] Campsites often have very primitive (if any) sanitation facilities, making them potentially as dangerous as any developing country.[ citation needed ]

Although travelers' diarrhea usually resolves within three to five days (mean duration: 3.6 days), in about 20% of cases, the illness is severe enough to require bedrest, and in 10%, the illness duration exceeds one week. [12] For those prone to serious infections, such as bacillary dysentery, amoebic dysentery, and cholera, TD can occasionally be life-threatening. [12] Others at higher-than-average risk include young adults, immunosuppressed persons, persons with inflammatory bowel disease or diabetes, and those taking H2 blockers or antacids. [11]

Immunity

Travelers often get diarrhea from eating and drinking foods and beverages that have no adverse effects on local residents. This is due to immunity that develops with constant, repeated exposure to pathogenic organisms. The extent and duration of exposure necessary to acquire immunity has not been determined; it may vary with each individual organism. A study among expatriates in Nepal suggests that immunity may take up to seven years to develop—presumably in adults who avoid deliberate pathogen exposure. [18] Conversely, immunity acquired by American students while living in Mexico disappeared, in one study, as quickly as eight weeks after cessation of exposure. [19]

Prevention

Sanitation

Recommendations include avoidance of questionable foods and drinks, on the assumption that TD is fundamentally a sanitation failure, leading to bacterial contamination of drinking water and food. [11] While the effectiveness of this strategy has been questioned, given that travelers have little or no control over sanitation in hotels and restaurants, and little evidence supports the contention that food vigilance reduces the risk of contracting TD, [20] guidelines continue to recommend basic, common-sense precautions when making food and beverage choices: [3]

If handled properly, thoroughly cooked fresh and packaged foods are usually safe. [11] Raw or undercooked meat and seafood should be avoided. Unpasteurized milk, dairy products, mayonnaise, and pastry icing are associated with increased risk for TD, as are foods and beverages purchased from street vendors and other establishments where unhygienic conditions may be present. [12]

Water

Although safe bottled water is now widely available in most remote destinations, travelers can treat their own water if necessary, or as an extra precaution. [12] Techniques include boiling, filtering, chemical treatment, and ultraviolet light; boiling is by far the most effective of these methods. [21] Boiling rapidly kills all active bacteria, viruses, and protozoa. Prolonged boiling is usually unnecessary; most microorganisms are killed within seconds at water temperature above 55–70 °C (130–160 °F). [22] [23] The second-most effective method is to combine filtration and chemical disinfection. [24] Filters eliminate most bacteria and protozoa, but not viruses. Chemical treatment with halogens—chlorine bleach, tincture of iodine, or commercial tablets—have low-to-moderate effectiveness against protozoa such as Giardia, but work well against bacteria and viruses. UV light is effective against both viruses and cellular organisms, but only works in clear water, and it is ineffective unless manufacturer's instructions are carefully followed for maximum water depth/distance from UV source, and for dose/exposure time. Other claimed advantages include short treatment time, elimination of the need for boiling, no taste alteration, and decreased long-term cost compared with bottled water. The effectiveness of UV devices is reduced when water is muddy or turbid; as UV is a type of light, any suspended particles create shadows that hide microorganisms from UV exposure. [25]

Medications

Bismuth subsalicylate four times daily reduces rates of travelers' diarrhea. [2] [26] Though many travelers find a four-times-per-day regimen inconvenient, lower doses have not been shown to be effective. [2] [26] Potential side effects include black tongue, black stools, nausea, constipation, and ringing in the ears. Bismuth subsalicylate should not be taken by those with aspirin allergy, kidney disease, or gout, nor concurrently with certain antibiotics such as the quinolones, and should not be taken continuously for more than three weeks.[ medical citation needed ] Some countries do not recommend it due to the risk of rare but serious side effects. [26]

A hyperimmune bovine colostrum to be taken by mouth is marketed in Australia for prevention of ETEC-induced TD. As yet, no studies show efficacy under actual travel conditions. [3]

Though effective, antibiotics are not recommended for prevention of TD in most situations because of the risk of allergy or adverse reactions to the antibiotics, and because intake of preventive antibiotics may decrease effectiveness of such drugs should a serious infection develop subsequently. Antibiotics can also cause vaginal yeast infections, or overgrowth of the bacterium Clostridium difficile , leading to pseudomembranous colitis and its associated severe, unrelenting diarrhea. [27]

Antibiotics may be warranted in special situations where benefits outweigh the above risks, such as immunocompromised travelers, chronic intestinal disorders, prior history of repeated disabling bouts of TD, or scenarios in which the onset of diarrhea might prove particularly troublesome. Options for prophylactic treatment include the quinolone antibiotics (such as ciprofloxacin), azithromycin, and trimethoprim/sulfamethoxazole, though the latter has proved less effective in recent years. [28] Rifaximin may also be useful. [26] [29] Quinolone antibiotics may bind to metallic cations such as bismuth, and should not be taken concurrently with bismuth subsalicylate. Trimethoprim/sulfamethoxazole should not be taken by anyone with a history of sulfa allergy.[ medical citation needed ]

Vaccination

The oral cholera vaccine, while effective for prevention of cholera, is of questionable use for prevention of TD. [6] A 2008 review found tentative evidence of benefit. [30] A 2015 review stated it may be reasonable for those at high risk of complications from TD. [3] Several vaccine candidates targeting ETEC or Shigella are in various stages of development. [31] [32]

Probiotics

One 2007 review found that probiotics may be safe and effective for prevention of TD, while another review found no benefit. [2] A 2009 review confirmed that more study is needed, as the evidence to date is mixed. [26]

Treatment

Most cases of TD are mild and resolve in a few days without treatment, but severe or protracted cases may result in significant fluid loss and dangerous electrolytic imbalance. Dehydration due to diarrhea can also alter the effectiveness of medicinal and contraceptive drugs. Adequate fluid intake (oral rehydration therapy) is therefore a high priority. Commercial rehydration drinks [33] are widely available; alternatively, purified water or other clear liquids are recommended, along with salty crackers or oral rehydration salts (available in stores and pharmacies in most countries) to replenish lost electrolytes. [11] Carbonated water or soda, left open to allow dissipation of the carbonation, is useful when nothing else is available. [12] In severe or protracted cases, the oversight of a medical professional is advised.[ citation needed ]

Antibiotics

If diarrhea becomes severe (typically defined as three or more loose stools in an eight-hour period), especially if associated with nausea, vomiting, abdominal cramps, fever, or blood in stools, medical treatment should be sought. Such patients may benefit from antimicrobial therapy. [11] A 2000 literature review found that antibiotic treatment shortens the duration and severity of TD; most reported side effects were minor, or resolved on stopping the antibiotic. [34]

The antibiotic recommended varies based upon the destination of travel. [35] Trimethoprim–sulfamethoxazole and doxycycline are no longer recommended because of high levels of resistance to these agents. [11] Antibiotics are typically given for three to five days, but single doses of azithromycin or levofloxacin have been used. [36] Rifaximin and rifamycin are approved in the U.S. for treatment of TD caused by ETEC. [37] [38] If diarrhea persists despite therapy, travelers should be evaluated for bacterial strains resistant to the prescribed antibiotic, possible viral or parasitic infections, [11] bacterial or amoebic dysentery, Giardia, helminths, or cholera. [12]

Antimotility agents

Antimotility drugs such as loperamide and diphenoxylate reduce the symptoms of diarrhea by slowing transit time in the gut. They may be taken to slow the frequency of stools, but not enough to stop bowel movements completely, which delays expulsion of the causative organisms from the intestines. [11] They should be avoided in patients with fever, bloody diarrhea, and possible inflammatory diarrhea. [39] Adverse reactions may include nausea, vomiting, abdominal pain, hives or rash, and loss of appetite. [40] Antimotility agents should not, as a rule, be taken by children under age two. [41] [42]

Epidemiology

An estimated 10 million people—20 to 50% of international travelers—develop TD each year. [11] It is more common in the developing world, where rates exceed 60%, but has been reported in some form in virtually every travel destination in the world. [43]

Society and culture

Moctezuma's revenge is a colloquial term for travelers' diarrhea contracted in Mexico. The name refers to Moctezuma II (1466–1520), the Tlatoani (ruler) of the Aztec civilization who was overthrown by the Spanish conquistador Hernán Cortés in the early 16th century, thereby bringing large portions of what is now Mexico and Central America under the rule of the Spanish crown. The relevance being that Cortés and his soldiers carried the smallpox virus. The Mexicans had never been exposed to the virus. The resulting infection reduced the population of Tenochtitlan by 40 percent in the single year of 1520. [44]

Wilderness diarrhea

Wilderness diarrhea, also called wilderness-acquired diarrhea (WAD) or backcountry diarrhea, refers to diarrhea among backpackers, hikers, campers and other outdoor recreationalists in wilderness or backcountry situations, either at home or abroad. [16] It is caused by the same fecal microorganisms as other forms of travelers' diarrhea, usually bacterial or viral. Since wilderness campsites seldom provide access to sanitation facilities, the infection risk is similar to that of any developing country. [17] Water treatment, good hygiene, and dish washing have all been shown to reduce the incidence of WAD. [45] [46]

Related Research Articles

<span class="mw-page-title-main">Cholera</span> Bacterial infection of the small intestine

Cholera is an infection of the small intestine by some strains of the bacterium Vibrio cholerae. Symptoms may range from none, to mild, to severe. The classic symptom is large amounts of watery diarrhea lasting a few days. Vomiting and muscle cramps may also occur. Diarrhea can be so severe that it leads within hours to severe dehydration and electrolyte imbalance. This may result in sunken eyes, cold skin, decreased skin elasticity, and wrinkling of the hands and feet. Dehydration can cause the skin to turn bluish. Symptoms start two hours to five days after exposure.

<i>Vibrio cholerae</i> Species of bacterium

Vibrio cholerae is a species of Gram-negative, facultative anaerobe and comma-shaped bacteria. The bacteria naturally live in brackish or saltwater where they attach themselves easily to the chitin-containing shells of crabs, shrimp, and other shellfish. Some strains of V. cholerae are pathogenic to humans and cause a deadly disease called cholera, which can be derived from the consumption of undercooked or raw marine life species or drinking contaminated water.

<span class="mw-page-title-main">Diarrhea</span> Loose or liquid bowel movements

Diarrhea, also spelled diarrhoea or diarrhœa, is the condition of having at least three loose, liquid, or watery bowel movements in a day. It often lasts for a few days and can result in dehydration due to fluid loss. Signs of dehydration often begin with loss of the normal stretchiness of the skin and irritable behaviour. This can progress to decreased urination, loss of skin color, a fast heart rate, and a decrease in responsiveness as it becomes more severe. Loose but non-watery stools in babies who are exclusively breastfed, however, are normal.

<span class="mw-page-title-main">Dysentery</span> Inflammation of the intestine causing diarrhea with blood

Dysentery, historically known as the bloody flux, is a type of gastroenteritis that results in bloody diarrhea. Other symptoms may include fever, abdominal pain, and a feeling of incomplete defecation. Complications may include dehydration.

<span class="mw-page-title-main">Shigellosis</span> Medical condition

Shigellosis is an infection of the intestines caused by Shigella bacteria. Symptoms generally start one to two days after exposure and include diarrhea, fever, abdominal pain, and feeling the need to pass stools even when the bowels are empty. The diarrhea may be bloody. Symptoms typically last five to seven days and it may take several months before bowel habits return entirely to normal. Complications can include reactive arthritis, sepsis, seizures, and hemolytic uremic syndrome.

<span class="mw-page-title-main">Giardiasis</span> Parasitic disease that results in diarrhea

Giardiasis is a parasitic disease caused by Giardia duodenalis. Infected individuals who experience symptoms may have diarrhoea, abdominal pain, and weight loss. Less common symptoms include vomiting and blood in the stool. Symptoms usually begin one to three weeks after exposure and, without treatment, may last two to six weeks or longer.

<span class="mw-page-title-main">Gastroenteritis</span> Inflammation of the stomach and small intestine

Gastroenteritis, also known as infectious diarrhea or simply as gastro, is an inflammation of the gastrointestinal tract including the stomach and intestine. Symptoms may include diarrhea, vomiting, and abdominal pain. Fever, lack of energy, and dehydration may also occur. This typically lasts less than two weeks. Although it is not related to influenza, in the U.S. and U.K., it is sometimes called the "stomach flu".

<span class="mw-page-title-main">Campylobacteriosis</span> Medical condition

Campylobacteriosis is among the most common infections caused by a bacterium in humans, often as a foodborne illness. It is caused by the Campylobacter bacterium, most commonly C. jejuni. It produces an inflammatory, sometimes bloody, diarrhea or dysentery syndrome, and usually cramps, fever and pain.

<span class="mw-page-title-main">Staphylococcal enteritis</span> Medical condition

Staphylococcal enteritis is an inflammation that is usually caused by eating or drinking substances contaminated with staph enterotoxin. The toxin, not the bacterium, settles in the small intestine and causes inflammation and swelling. This in turn can cause abdominal pain, cramping, dehydration, diarrhea and fever.

<span class="mw-page-title-main">Travel medicine</span> Branch of medicine

Travel medicine or emporiatrics is the branch of medicine that deals with the prevention and management of health problems of international travelers.

<span class="mw-page-title-main">Oral rehydration therapy</span> Type of fluid replacement used to prevent and treat dehydration

Oral rehydration therapy (ORT) is a type of fluid replacement used to prevent and treat dehydration, especially due to diarrhea. It involves drinking water with modest amounts of sugar and salts, specifically sodium and potassium. Oral rehydration therapy can also be given by a nasogastric tube. Therapy can include the use of zinc supplements to reduce the duration of diarrhea in infants and children under the age of 5. Use of oral rehydration therapy has been estimated to decrease the risk of death from diarrhea by up to 93%.

<i>Cryptosporidium</i> Genus of single-celled organisms

Cryptosporidium, sometimes called crypto, is an apicomplexan genus of alveolates which are parasites that can cause a respiratory and gastrointestinal illness (cryptosporidiosis) that primarily involves watery diarrhea, sometimes with a persistent cough.

Wilderness-acquired diarrhea is a variety of traveler's diarrhea in which backpackers and other outdoor enthusiasts are affected. Potential sources are contaminated food or water, or "hand-to-mouth", directly from another person who is infected. Cases generally resolve spontaneously, with or without treatment, and the cause is typically unknown. The National Outdoor Leadership School has recorded about one incident per 5,000 person-field days by following strict protocols on hygiene and water treatment. More limited, separate studies have presented highly varied estimated rates of affliction that range from 3 percent to 74 percent of wilderness visitors. One survey found that long-distance Appalachian Trail hikers reported diarrhea as their most common illness. Based on reviews of epidemiologic data and literature, some researchers believe that the risks have been over-stated and are poorly understood by the public.

Enterotoxigenic Escherichia coli (ETEC) is a type of Escherichia coli and one of the leading bacterial causes of diarrhea in the developing world, as well as the most common cause of travelers' diarrhea. Insufficient data exists, but conservative estimates suggest that each year, about 157,000 deaths occur, mostly in children, from ETEC. A number of pathogenic isolates are termed ETEC, but the main hallmarks of this type of bacterium are expression of one or more enterotoxins and presence of fimbriae used for attachment to host intestinal cells. The bacterium was identified by the Bradley Sack lab in Kolkata in 1968.

<span class="mw-page-title-main">Rifaximin</span> Antibiotic medication

Rifaximin, is a non-absorbable, broad spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in over more than 30 countries for the treatment of a variety of gastrointestinal diseases like irritable bowel syndrome, and hepatic encephalopathy. It acts by inhibiting RNA synthesis in susceptible bacteria by binding to the RNA polymerase enzyme. This binding blocks translocation, which stops transcription. It is marketed under the brand name Xifaxan by Salix Pharmaceuticals.

<span class="mw-page-title-main">Portable water purification</span> Self-contained, easily transported units used to purify water from untreated sources

Portable water purification devices are self-contained, easily transported units used to purify water from untreated sources for drinking purposes. Their main function is to eliminate pathogens, and often also of suspended solids and some unpalatable or toxic compounds.

The discovery of disease-causing pathogens is an important activity in the field of medical science. Many viruses, bacteria, protozoa, fungi, helminths, and prions are identified as a confirmed or potential pathogen. In the United States, a Centers for Disease Control and Prevention program, begun in 1995, identified over a hundred patients with life-threatening illnesses that were considered to be of an infectious cause but that could not be linked to a known pathogen. The association of pathogens with disease can be a complex and controversial process, in some cases requiring decades or even centuries to achieve.

<span class="mw-page-title-main">Amoebiasis</span> Human disease caused by amoeba protists

Amoebiasis, or amoebic dysentery, is an infection of the intestines caused by a parasitic amoeba Entamoeba histolytica. Amoebiasis can be present with no, mild, or severe symptoms. Symptoms may include lethargy, loss of weight, colonic ulcerations, abdominal pain, diarrhea, or bloody diarrhea. Complications can include inflammation and ulceration of the colon with tissue death or perforation, which may result in peritonitis. Anemia may develop due to prolonged gastric bleeding.

Pathogenic <i>Escherichia coli</i> Strains of E. coli that can cause disease

Escherichia coli is a gram-negative, rod-shaped bacterium that is commonly found in the lower intestine of warm-blooded organisms (endotherms). Most E. coli strains are harmless, but pathogenic varieties cause serious food poisoning, septic shock, meningitis, or urinary tract infections in humans. Unlike normal flora E. coli, the pathogenic varieties produce toxins and other virulence factors that enable them to reside in parts of the body normally not inhabited by E. coli, and to damage host cells. These pathogenic traits are encoded by virulence genes carried only by the pathogens.

Enteroaggregative Escherichia coli are a pathotype of Escherichia coli which cause acute and chronic diarrhea in both the developed and developing world. They may also cause urinary tract infections. EAEC are defined by their "stacked-brick" pattern of adhesion to the human laryngeal epithelial cell line HEp-2. The pathogenesis of EAEC involves the aggregation of and adherence of the bacteria to the intestinal mucosa, where they elaborate enterotoxins and cytotoxins that damage host cells and induce inflammation that results in diarrhea.

References

  1. 1 2 Ensminger, Marion Eugene; Ensminger, Audrey H. (1993-11-09). Foods & Nutrition Encyclopedia, Two Volume Set. CRC Press. p. 143. ISBN   9780849389801.
  2. 1 2 3 4 5 6 7 8 9 10 Giddings, SL; Stevens, AM; Leung, DT (March 2016). "Traveler's Diarrhea". The Medical Clinics of North America. 100 (2): 317–30. doi:10.1016/j.mcna.2015.08.017. PMC   4764790 . PMID   26900116.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Leder, K (2015). "Advising travellers about management of travellers' diarrhoea". Australian Family Physician. 44 (1–2): 34–37. PMID   25688957. Archived from the original on 2017-01-12.
  4. 1 2 3 4 5 "Travelers' Diarrhea". cdc.gov. April 26, 2013. Archived from the original on March 13, 2016.
  5. Feldman, Mark (2015). Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management (10th ed.). Elsevier Health Sciences. p. 1924. ISBN   9781455749898. Archived from the original on 2016-03-10.
  6. 1 2 Ahmed, T; Bhuiyan, TR; Zaman, K; Sinclair, D; Qadri, F (5 July 2013). "Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea". The Cochrane Database of Systematic Reviews. 7 (7): CD009029. doi:10.1002/14651858.CD009029.pub2. PMC   6532719 . PMID   23828581.
  7. "Health Information for Travelers to Singapore - Clinician view | Travelers' Health | CDC". wwwnc.cdc.gov. Retrieved 5 February 2019.
  8. Diemert, D. J. (17 July 2006). "Prevention and Self-Treatment of Traveler's Diarrhea". Clinical Microbiology Reviews. 19 (3): 583–594. doi:10.1128/CMR.00052-05. PMC   1539099 . PMID   16847088.
  9. "Traveler's Diarrhea-Topic Overview". WebMD. 2013-03-27. Archived from the original on 2015-06-30. Retrieved 2015-07-02. Traveler's diarrhea is sometimes called by its more colorful names: Montezuma's revenge, Delhi belly, and Turkey trots.
  10. Waln, Olga; Jankovic, Joseph (2013-07-12). "An Update on Tardive Dyskinesia: From Phenomenology to Treatment". Tremor and Other Hyperkinetic Movements. 3: tre-03-161-4138-1. doi: 10.5334/tohm.165 . ISSN   2160-8288. PMC   3709416 . PMID   23858394.
  11. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 "Travelers' Diarrhea". Centers for Disease Control and Prevention. November 21, 2006. Archived from the original on April 3, 2008.
  12. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 "Travelers' diarrhea". safewateronline.com. Archived from the original on 6 June 2008.
  13. Hampson, David J. (2017-11-29). "The Spirochete Brachyspira pilosicoli, Enteric Pathogen of Animals and Humans". Clinical Microbiology Reviews. 31 (1). doi:10.1128/CMR.00087-17. ISSN   0893-8512. PMC   5740978 . PMID   29187397.
  14. Thorell, Kaisa; Inganäs, Linn; Backhans, Annette; Agréus, Lars; Öst, Åke; Walker, Marjorie M.; Talley, Nicholas J.; Kjellström, Lars; Andreasson, Anna; Engstrand, Lars (2019-10-04). "Isolates from Colonic Spirochetosis in Humans Show High Genomic Divergence and Potential Pathogenic Features but Are Not Detected Using Standard Primers for the Human Microbiota". Journal of Bacteriology. 201 (21). doi:10.1128/JB.00272-19. ISSN   0021-9193. PMC   6779451 . PMID   31405919.
  15. Ortega, Ynés R.; Sanchez, Roxana (2010). "Update on Cyclospora cayetanensis, a Food-Borne and Waterborne Parasite". Clinical Microbiology Reviews. 23 (1): 218–234. doi:10.1128/CMR.00026-09. PMC   2806662 . PMID   20065331.
  16. 1 2 Zell SC (1992). "Epidemiology of Wilderness-acquired Diarrhea: Implications for Prevention and Treatment". J Wilderness Med. 3 (3): 241–9. doi:10.1580/0953-9859-3.3.241. S2CID   73001096.
  17. 1 2 Hargreaves JS (2006). "Laboratory evaluation of the 3-bowl system used for washing-up eating utensils in the field". Wilderness Environ Med. 17 (2): 94–102. doi: 10.1580/PR17-05.1 . PMID   16805145.
  18. David R. Shlim, Understanding Diarrhea in Travelers. A Guide to the Prevention, Diagnosis, and Treatment of the World's Most Common Travel-Related Illness Archived 2008-05-24 at the Wayback Machine . CIWEC Clinic Travel Medicine Center, 2004.
  19. Luis Ostrosky-Zeichner, Charles D. Ericsson, Travelers' diarrhea. In Jane N. Zucherman, Ed., Principles and Practice of Travel Medicine, John Wiley and Sons, 2001. p.153 Google books preview Archived 2017-09-08 at the Wayback Machine
  20. Shlim, DR (1 December 2005). "Looking for evidence that personal hygiene precautions prevent traveler's diarrhea". Clinical Infectious Diseases. 41 (Suppl 8): S531–5. doi: 10.1086/432947 . PMID   16267714.
  21. "Water Disinfection for Travelers - Chapter 2 - 2018 Yellow Book | Travelers' Health | CDC".
  22. National Advisory Committee on Microbiological Criteria for Foods: Requisite Scientific Parameters for Establishing the Equivalence of Alternative Methods of Pasteurization, USDA, 2004
  23. McGee, Harold (2011-08-23). "Bending the Rules on Bacteria and Food Safety". The New York Times. Archived from the original on 2017-09-08. Retrieved 2014-10-24.{{cite news}}: CS1 maint: bot: original URL status unknown (link). Retrieved October 24, 2014.
  24. "Drinking Water Treatment Methods for Backcountry and Travel Use" (PDF). www.cdc.gov.
  25. Ultraviolet Light Disinfection in the Use of Individual Water Purification Devices. Technical Information Paper # 31-006-0211 U.S. Army Public Health Command Archived 2014-03-08 at the Wayback Machine , retrieved January 5, 2016.
  26. 1 2 3 4 5 DuPont, HL; Ericsson, CD; Farthing, MJ; Gorbach, S; Pickering, LK; Rombo, L; Steffen, R; Weinke, T (2009). "Expert review of the evidence base for prevention of travelers' diarrhea". Journal of Travel Medicine. 16 (3): 149–60. doi: 10.1111/j.1708-8305.2008.00299.x . PMID   19538575.
  27. Travelers' Diarrhea. The Travel Doctor Archived 2011-02-01 at the Wayback Machine Retrieved March 21, 2011.
  28. Adachi J, et al. Empirical Antimicrobial Therapy for Traveler's Diarrhea. Clinical Infectious Diseases; Vol. 31 Issue 4 (10/1/2000), p1079.
  29. DuPont, H (2007). "Therapy for and Prevention of Traveler's Diarrhea". Clinical Infectious Diseases. 45 (45 (Suppl 1)): S78–S84. doi: 10.1086/518155 . PMID   17582576.
  30. Jelinek T, Kollaritsch H (2008). "Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera". Expert Rev Vaccines. 7 (5): 561–7. doi:10.1586/14760584.7.5.561. PMID   18564011. S2CID   20442764.
  31. World Health Organization. Enterotoxigenic Escherichia coli (ETEC). Archived 2012-05-15 at the Wayback Machine
  32. "World Health Organization. Shigellosis". who.int. Archived from the original on 2008-12-15.
  33. Rehydration drinks. EMedicineHealth.com. Archived 2014-08-19 at the Wayback Machine Retrieved August 18, 2014.
  34. De Bruyn G, Hahn S, Borwick A (2000). "Antibiotic treatment for travellers' diarrhoea". Cochrane Database of Systematic Reviews. 2000 (3): CD002242. doi:10.1002/14651858.CD002242. PMC   6532602 . PMID   10908534.
  35. "Travelers' Diarrhea". CDC. Retrieved 19 November 2018.
  36. Sanders JW, Frenck RW, Putnam SD, et al. (August 2007). "Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey". Clin. Infect. Dis. 45 (3): 294–301. doi: 10.1086/519264 . PMID   18688944.
  37. "Xifaxan label information" (PDF). Food and Drug Administration . Retrieved November 15, 2008.
  38. "Press Announcements - FDA approves new drug to treat travelers' diarrhea". www.fda.gov. Retrieved 19 November 2018.
  39. "Disease Management Project - Missing Chapter". Archived from the original on 2016-03-04. Retrieved 2015-07-25.
  40. Diphenoxylate package insert. Drugs.com. Archived 2011-06-22 at the Wayback Machine Retrieved 2010-10-07.
  41. "Imodium (Loperamide Hydrochloride) Capsule". DailyMed. NIH. Archived from the original on 13 April 2010.
  42. Li ST, Grossman DC, Cummings P (2007). "Loperamide therapy for acute diarrhea in children: systematic and meta-analysis". PLOS Medicine. 4 (3): e98. doi: 10.1371/journal.pmed.0040098 . PMC   1831735 . PMID   17388664.
  43. Steffen, R (Dec 1, 2005). "Epidemiology of traveler's diarrhea". Clinical Infectious Diseases. 41 (Suppl 8): S536–40. doi: 10.1086/432948 . PMID   16267715.
  44. Gunderman, Richard (2019-02-19). "How smallpox devastated the Aztecs – and helped Spain conquer an American civilization 500 years ago". The Conversation . Retrieved 2023-05-29.
  45. Boulware, DR (2003). "Medical risks of wilderness hiking". American Journal of Medicine. 114 (March): 288–93. doi:10.1016/S0002-9343(02)01494-8. PMID   12681456.
  46. McIntosh, SE (2007). "Medical Incidents and Evacuations on Wilderness Expeditions". Wilderness and Environmental Medicine. 18 (Winter): 298–304. doi:10.1580/07-WEME-OR-093R1.1. PMID   18076301. S2CID   1401977.

PD-icon.svg This article incorporates public domain material from websites or documents of the Centers for Disease Control and Prevention .